RA
Aymon, Romain Victor Rudolf
Affiliation entities
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs : data from an international collaboration of registries (the "JAK-pot" study) | Arthritis & rheumatology | 2025 | 44 | 24 | |||
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study) | Annals of the rheumatic diseases | 2024 | 78 | 38 | |||
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA | BMJ open | 2024 | 102 | 36 | |||
A potential role for chlamydial infection in rheumatoid arthritis development | Rheumatology | 2023 | 68 | 73 | |||
Identifying risk factors associated with major complications and refractory course in patients with osteomyelitis of the jaw : a retrospective study | Journal of clinical medicine | 2023 | 73 | 60 | |||
Does the type of craniomaxillofacial fracture (CMF) differ between patients with intracranial hemorrhage (ICH) and those with blunt cerebrovascular injury (BCVI)? A retrospective study | Journal of cranio-maxillofacial surgery | 2023 | 88 | 90 |